×
News Home

Is Cara Therapeutics Inc (CARA) Stock at the Top of the Biotechnology Industry?

Friday, August 27, 2021 01:46 PM | InvestorsObserver Analysts
Is Cara Therapeutics Inc (CARA) Stock at the Top of the Biotechnology Industry?

A rating of 72 puts Cara Therapeutics Inc (CARA) near the top of the Biotechnology industry according to InvestorsObserver. Cara Therapeutics Inc's score of 72 means it scores higher than 72% of stocks in the industry. Cara Therapeutics Inc also received an overall rating of 47, putting it above 47% of all stocks. Biotechnology is ranked 88 out of the 148 industries.

Overall Score - 47
CARA has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on CARA!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 47 would rank higher than 47 percent of all stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Cara Therapeutics Inc Stock Today?

Cara Therapeutics Inc (CARA) stock is trading at $14.57 as of 1:28 PM on Friday, Aug 27, an increase of $0.91, or 6.66% from the previous closing price of $13.66. The stock has traded between $13.60 and $14.84 so far today. Volume today is below average. So far 1,683,078 shares have traded compared to average volume of 2,383,157 shares. Click Here to get the full Stock Report for Cara Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App